Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
sukycospito the chart for AIDO and CYGX are very close both hit 1.20 mark and both when to the .20s mark .and both are going up again.
specul8 NITE just raised its ask from .31 to .37 cents something is afoot
peace you should be glad you were not on the good old boy email insider information loop they scared themselves out of a lot of shares ,and now they are mad it didn't go down.
arnold again did you read the article? The fund is for small start up companies with hugh potential and yes Cytogenix is in this catagory.
arnold did you read Tatonkano62 post? Cytogenix is mentioned in a major article about financing. I hope the bashers didn't make you sell your shares .Only the true believers of this science will hold this stock and be rewarded.
Howard's hunch it being positive ,woodrow's hunch being negative, this board is going wild on rumors ,hunches ,stories .Then woodrow getting all high and mighty like his crap is gospel , gives us a break.No matter what we say or think Cytogenix will continue to be accumulated .People are buying this stock ,the science is to great.
It would be good if the CEO would give us the share holders an update at the web sight just to let us know how things are progressing .Also with all the lawyers on our team don't you think if it was a chance of cytogenix loosing to PP don't you think they would have come to agreement between the two before going to court.
skoobyfl1 this also could be a very cleverly orchestrated senario to try to lower PPS so that certain people can buy alot of shares at a discount ,just remember the folks at Cytogenix are buying and if they thought they could lose they would not have bought .I am sleeping soundly tonight.
howardjoel exactly .I think I would be more concerned if phanuel was sueing for a low amount than this outrageous amount. It tells me that we are sitting on a trillion dollar company .Also Mr Ocampo is a lawyer on Cytogenix side and also Malcolom is a lawyer ,I would think we have all the cards in this case and Phanuel is blowing smoke.If we didn't a deal will be struck shortly, no one wants litigation ,the costs on both sides will be prohibitive.
Hanuman .I just looked at the last 3 month of news Cytogenix had, they did alot of work.We should be seeing financing soon.Its very good the company has all these patents.
--------------------------------------------------------------------------------
Ownership: Public
Symbol: CYGX (NASDAQ Bulletin Board)
--------------------------------------------------------------------------------
CytoGenix, Inc. (CYGX) Antimicrobial Compound Is Active Against The Most Resistant Bacteria Strain
CytoGenix Inc. (OTCBB:CYGX) announces the results of a pre-clinical proof-of-concept study demonstrating that its antimicrobial compound CY401 is active against Vancomycin-resistant Staphylococcus aureus (VRSA). This laboratory study demonstrated that CytoGenix CY401 inhibits growth of VRSA, bacteria that are resistant to approved doses of all antibiotic products.
(See Story from BioSpace.com) (10/26/04)
CytoGenix, Inc. (CYGX) Announces A Pre-Clinical Research Agreement With Baylor College of Medicine To Test An Agent Against Deadly Resistant Bacteria
CytoGenix Inc. (OTCBB:CYGX) announces that it has entered into an agreement with the Section of Pediatric Infectious Diseases of Baylor College of Medicine, for mice and cell studies using the company's new antimicrobial agent against a highly dangerous strain of Staphylococcus aureus bacteria.
(See Story from BioSpace.com) (10/21/04)
CytoGenix, Inc. (CYGX) Files U.S. Patent Application For New Class Of Antibacterial Agent
CytoGenix Inc. (OTCBB:CYGX) announces the filing on Sept. 28, 2004, of a patent application with the U.S. Patent and Trademark Office for an invention titled A Novel Genomic Approach Identifies Bacterial DNA-Dependent RNA Polymerase as the Target of an Antibacterial Oligodeoxynucleotide, RBL1.
(See Story from BioSpace.com) (9/30/04)
NASA Contractor Senior Scientist Joins CytoGenix, Inc. (CYGX)
CytoGenix Inc. (OTCBB:CYGX) announces that Kurt L. Berens has agreed to join the company as Vice President of Product Development. Formerly a Section Manager for Wyle Laboratories, Cellular and Biomedical Group at NASA-Johnson Space Center, Houston, Berens has over fifteen years of clinical research experience.
(See Story from BioSpace.com) (9/14/04)
CytoGenix, Inc. (CYGX) CEO Dr. Malcolm Skolnick Invited To Participate In Corporate Governance Panel
CytoGenix Inc. (OTCBB:CYGX) announces that Dr. Malcolm Skolnick, CytoGenix CEO, was invited to participate with other Houston business leaders in a panel discussion of corporate integrity issues, the Sarbanes-Oxley Corporate Fraud and Accountability Act of 2002, and how these impact the conduct and cost of doing business.
(See Story from BioSpace.com) (9/8/04)
CytoGenix, Inc. (CYGX) Initiates Planned Expansion Of Its Scientific Staff
CytoGenix Inc. (OTCBB:CYGX) announces the expansion of its product development efforts with the addition of Dr. Frederic Kendirgi to the company's scientific staff. Dr. Kendirgi has broad experience in developing virology and immunology assays for protein function and expression vectors. He received a Ph.D. in biochemistry and molecular biology from the University of Calgary, and he has authored five scientific papers.
(See Story from BioSpace.com) (8/26/04)
CytoGenix, Inc. (CYGX) President Interviewed By WallStreetReporter.com
CytoGenix Inc. (OTCBB:CYGX) today announced that Dr. Malcolm Skolnick, chairman, president and CEO was interviewed by WallStreetReporter.com a leading financial news and information portal.
(See Story from BioSpace.com) (8/13/04)
CytoGenix, Inc. (CYGX) President Interviewed By CEOcast
CytoGenix Inc. (OTCBB:CYGX) today announced that Dr. Malcolm Skolnick, chairman, president and CEO was interviewed by CEOcast on Aug. 10, 2004.
(See Story from BioSpace.com) (8/12/04)
CytoGenix, Inc. (CYGX) Announces Successful Completion Of Pre-Clinical Anti-Herpes Safety Studies
CytoGenix, Inc. (OTCBB:CYGX) announced the successful completion of pre-clinical animal safety studies. These standard studies show that the company's lead DNA anti-herpes topical compound is safe in three species of animals. A third party laboratory conducted the tests operating under FDA Good Laboratory Practices (GLP) regulations and following United States Pharmacopeia (USP) testing standards for topical products.
(See Story from BioSpace.com) (8/3/04)
CytoGenix, Inc. (CYGX) Files International Patent Applications For New Class Of Antibacterial And Antifungal Agents
CytoGenix Inc. (OTCBB:CYGX) announced today that it has filed new patent applications for Nucleotides for Prevention and Treatment of Bacterial and Fungal Pathologies under the Patent Cooperation Treaty (PCT) of the World Intellectual Property Organization (WIPO).
It would be nice if Cytogenix could get some of that money and right in the middle of Texas.Could some one E Mail that article please to CYGX.
M&Ms can do anything on low volume this is the time that they try to get cheap shares for the next run.If it was high volume and it goes down that would be bad.Buy on the dips and hold when this runs it will take you breath away.
AVI biopharma has a lack of patents .I could not find one, am I missing something.You would think they would have a few .CYGX has many ,I wonder if they are using Cytogenix tech or others for the discoveries .
Red Sox win !!!
PARMEN 43 MINUTES INTO THE SHOW cygx WAS MENTIONED SHOULD GO TO .50 CENTS .AND HE WAS TALKING TO DAY TRADERS .
skoobyfl1 don't get to mad at him he is the type that can see the tiny bit of sand in other peoples eyes but he is missing the bolder in his own eye.
Market makers brought it down quick at the end of the day they are short and are trying to start a sell off .I predicted last week we should see the mid .30s this week we did and now tomorrow we should see the market makers try to bring it down more . If you can buy on the dips tomorrow.
parmen is that exacly 30 minutes into program.
Good volume today .EOM
I think the news is being digested well today ,people are realizing the potential gold mine this is.
.39 cents yes
Next thing to look forward to is a new up date at the Cytogenix website by our CEO , and maybe a grant or two,and some funding news would be nice ,and a news spot on a national news channel would be good and news on the lung cancer aerosol using CYGX technology,I could go on and on but you see the potential here ,just sitting back and smiling and thinking of the future,and of course looking at the ball game.Life is good.
Big B good to see you back .Slime bag LO take about you on the raging bull board today ,I bet he wished he had stocked up on CYGX when it was low.All he has is his big mouth and no stock.
100 million dollars in public and private funds .If we could get just 10 million dollars of that money we could be saving lives next year, not in ten years with Genome based cures.Not to say its not important work but lets be real.
One estimate, however, places the annual cost of antibiotic resistance as high as $5 billion per year." If we could get just 10% of this market it would be 500 million dollars a year that would make us worth 50 dollars a share at the 10 times PE rate that is common to most stock.And that is just for one pony show.Cytogenix has many irons in the fire ,our time is near.
The entire world will be looking at us in the next few days when the news is completely digested ,this is the point in time we have been waiting for ,its all good from here ,good luck to all our team at Cytogenix and thanks.
CLBE is doing well.CYGX to follow.
Anyone one notice that NITE is buying at .26 and going to sell at .31 this week we could see mid .30s I think it will be up from here.
schrodbox you may have hit the nail on this one.
CYGX was getting a little queasy about letting PP oversee the clinical trials being performed by Biocon. That is an awful lot of proprietary scientific knowledge to give away to a fly-by-night offshore venture capitalist and a foreign biopharmaceutical company. Patents do not mean that much in that part of the world. Required disclaimer IMO.
CYGX is to supply the SS DNA material for the tests ,part of the funding was to be used for the lab to make a bigger quantity of material for the tests .M S knows how foreign companies take and steal ideas and the ways of making the material had to be safe guarded .PP may have been trying to make the SS dna on their own and may have broken a legal part of the agreement.Just my guess.
Also interesting.
http://www.nyas.org/sa/career/career.asp?articleID=17
John Wilson PHD , skooby do you think this paper he wrote is influence by Cytogenix SS DNA ?
http://www.bcm.edu/biochem/fac/wilson/wilson.html
DRCAL what is the shares outstanding and float of DNAP.Thanks
What makes you think that Paul J Goldman did not already sell. In August their were a lot of sells.And try not to be such a hot head or change your name so you won't be such a hypocrite .Just remember this is not the animal board like Raging Bull board is.Try to relax, and I forgive you this time.
Peace to all, chill or change your name to hate to all, you may not know it but you are turning into a LO type basher ,
" everything these bozozs do affects me and my money and I am not going to sit around and watch these inept guys enrich their crooks at my expense ".
" sweateheart deal with their cohorts who are nothing but scammers hurting shareholders like us."
It looks like you put your money before people and their feelings .If I were a new potential shareholder I would think twice on buying .We see how you hate the management so give it a rest .Its very easy to be a back seat driver .Sit back and relax and give it a rest.
Howard Is this it.
) Investment Opportunities in Drug Delivery - In an in-depth (4,100 words) Analyst Interview, Gary B. Davis, a Managing Director and Senior Security Analyst at Jesup & Lamont Securities, examines the outlook for the sector and shares specific stock recommendations.
Volume is not listed
http://www.berlinerboerse.de/index.html?LANG=en
Today berlin was bullish for Cytogenix ,I wonder if the Germans are biotech smart than the Americans?
Arnold you are missing a few factors .One, CYGX is .29 cents a share that is what its worth to buy it .Two ,factor in market manipulation.Three,factor in berlin stock exchange.Four ,factor in that not many people know of Cytogenix yet .Five,factor in that people don't buy a stock for what its worth but what its potential will be worth in the future. Now,five is the key and when the population finds out about the inventions of Cytogenix the pps will have a major upward movement.People are holding very tight to cytogenix shares, this stock trades like a stock with 5 million in the float not 100 million.It is not if the pps will go up but when .This is the time when smart people are buying and the last of the day traders are selling.I see the glass half full and I am ready to see the cup flow over.
DRCAL ,ADVR has 600 million shares out worth .10 cents a share.We CYGX should be at one dollar and seventy five cents $1.75 compared to ADVR. CYGX little over 100 million shares out at .29 cents a share.Our time is near.Our technology is so far advanced compared to ADVR , cytogenix is so undervalued ,we should see some upward motion soon.Good to see yah.
That's good.